Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey

BÜYÜKCAM, AYŞE; Güdücüoğlu, Hüseyin; Karaman, Kamuran; Gurbuz, Venhar; Aliyev, Emil; KARA, ATEŞ; CEYHAN, MEHMET

doi:10.1080/21645515.2017.1331802

Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey

Atıf İçin Kopyala

BÜYÜKCAM A., Güdücüoğlu H., Karaman K., Gurbuz V., Aliyev E., KARA A., ...Daha Fazla

HUMAN VACCINES & IMMUNOTHERAPEUTICS, cilt.13, sa.8, ss.1892-1894, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 13 Sayı: 8
Basım Tarihi: 2017
Doi Numarası: 10.1080/21645515.2017.1331802
Dergi Adı: HUMAN VACCINES & IMMUNOTHERAPEUTICS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1892-1894
Hacettepe Üniversitesi Adresli: Evet

Özet

Invasive pneumococcal infections among children are a serious public health problem in many countries, including Turkey. Pneumococcal conjugate vaccine has been included in Turkey's National Immunization Programme since 2009. We report the first two pediatric cases of invasive pneumococcal infection due to non-vaccine serotype 15A after pneumococcal conjugate vaccine implementation in Turkey. It is essential to monitor the countries' own local seroepidemiologic data for detecting selective pressure of non-vaccine serotypes of S. pneumonia.